http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IE-42445-L

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da54f7ebbd2d9d8a82f92aca4d1b4e48
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-832
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-911
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J63-008
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J63-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-185
filingDate 1975-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1976-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber IE-42445-L
titleOfInvention Spacer for linear bodies
abstract D-Homo-21-carboxylic acids of the formula <IMAGE> the represents a single bond or a double bond; X is a hydrogen atom, a fluorine atom, or methylene; Y is a hydrogen atom, a fluorine atom, or a chlorine atom; Z is methylene, carbonyl, beta -hydroxymethylene, a beta -alkanoyloxymethylene or when Y is a chlorine atom, also beta -fluoromethylene or beta -chloromethylene; R1 is a hydrogen atom or methyl; and R2 is a hydrogen atom, hydroxy or alkanoyloxy; and their physiologically acceptable salts with bases and the 21-esters thereof, possess topical anti-inflammatory activity.n[US4033995A]
priorityDate 1974-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393818
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457192620
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457280508
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310

Total number of triples: 20.